Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
Multicentre, multinational, prospective randomised, open-label, 3 sequence crossover phase
III b clinical trial with blinded endpoint assessment (PROBE-design)
- in 75 patients with sporadic small vessel diseases (SVDs) and
- in 30 patients with cerebral autosomal dominant arteriopathy with subcortical infarcts
and leukoencephalopathy (CADASIL)
Phase:
Phase 3
Details
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborators:
Maastricht University Medical Center UMC Utrecht University of Edinburgh University of Oxford